XML 14 R4.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2018
Jun. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Income Statement [Abstract]        
Licensing revenue $ 125,000 $ 125,000 $ 375,000 $ 375,000
Operating expenses:        
Research and development 2,187,317 3,348,847 9,521,937 9,870,754
General and administrative 1,959,903 1,174,250 7,167,740 4,291,482
Total operating expenses 4,147,220 4,523,097 16,689,677 14,162,236
Loss from operations (4,022,220) (4,398,097) (16,314,677) (13,787,236)
Other (expense) income:        
Gain from change in valuation of earn-out milestone liability 4,114,995 1,246,151 3,567,671 670,172
Impairment of in-process research and development (4,510,000) (2,520,000) (4,510,000) (2,520,000)
Investment income 106,565 524 253,750 3,941
Interest expense (345,728) (360,759) (91,756)
Other income 2 93 78 3,545
Total other (expense) income, net (634,166) (1,273,232) (1,049,260) (1,934,098)
Net loss (4,656,386) (5,671,329) (17,363,937) (15,721,334)
Deemed dividend related to warrant modification (345,685)
Net loss attributable to common shareholders $ (4,656,386) $ (5,671,329) $ (17,363,937) $ (16,067,019)
Net loss per common share        
Basic and diluted $ (0.26) $ (0.70) $ (1.00) $ (3.04)
Weighted average shares outstanding        
Basic and diluted 17,801,230 8,054,658 17,447,921 5,171,699